ProMIS Neurosciences, Inc. (PMN)
14.85
-1.00
(-6.31%)
USD |
NASDAQ |
Mar 26, 15:58
ProMIS Neurosciences Free Cash Flow : -27.36M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Oncolytics Biotech, Inc. | -18.79M |
| Aurinia Pharmaceuticals, Inc. | 135.69M |
| Edesa Biotech, Inc. | -8.004M |
| Lexaria Bioscience Corp. | -8.775M |
| Xenon Pharmaceuticals, Inc. | -280.51M |
Free Cash Flow Related Metrics
| Free Cash Flow Per Share (Quarterly) | -5.217 |
| Free Cash Flow to Equity (Quarterly) | -10.19M |
| Free Cash Flow to Firm (Quarterly) | -10.19M |
| Free Cash Flow Yield | -18.65% |